Celldex Therapeutics, Inc. Quarterly Debt-to-equity in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Celldex Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2012 to Q2 2024.
  • Celldex Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 5.68 %, a 24.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 5.68 -1.82 -24.3% Jun 30, 2024
Q1 2024 6.81 -1.4 -17% Mar 31, 2024
Q4 2023 9.04 +1.08 +13.6% Dec 31, 2023
Q3 2023 8.99 +1.6 +21.7% Sep 30, 2023
Q2 2023 7.5 +0.55 +7.92% Jun 30, 2023
Q1 2023 8.21 +1.47 +21.8% Mar 31, 2023
Q4 2022 7.96 +0.18 +2.32% Dec 31, 2022
Q3 2022 7.38 -2.12 -22.3% Sep 30, 2022
Q2 2022 6.95 -5.24 -43% Jun 30, 2022
Q1 2022 6.74 -4.74 -41.3% Mar 31, 2022
Q4 2021 7.77 -5.89 -43.1% Dec 31, 2021
Q3 2021 9.5 -6.98 -42.4% Sep 30, 2021
Q2 2021 12.2 -9.28 -43.2% Jun 30, 2021
Q1 2021 11.5 -19.6 -63% Mar 31, 2021
Q4 2020 13.7 -16.7 -55% Dec 31, 2020
Q3 2020 16.5 -12.5 -43.1% Sep 30, 2020
Q2 2020 21.5 -7.91 -26.9% Jun 30, 2020
Q1 2020 31.1 -0.8 -2.51% Mar 31, 2020
Q4 2019 30.4 -4.53 -13% Dec 31, 2019
Q3 2019 29 -7.26 -20% Sep 30, 2019
Q2 2019 29.4 -10.6 -26.6% Jun 30, 2019
Q1 2019 31.9 -10.9 -25.5% Mar 31, 2019
Q4 2018 34.9 -8.56 -19.7% Dec 31, 2018
Q3 2018 36.2 -9.94 -21.5% Sep 30, 2018
Q2 2018 40 +0.54 +1.37% Jun 30, 2018
Q1 2018 42.8 +11.6 +37% Mar 31, 2018
Q4 2017 43.5 +19.8 +83.7% Dec 31, 2017
Q3 2017 46.2 +30.1 +188% Sep 30, 2017
Q2 2017 39.5 +25 +172% Jun 30, 2017
Q1 2017 31.2 +18 +136% Mar 31, 2017
Q4 2016 23.7 +12.3 +108% Dec 31, 2016
Q3 2016 16 +4.87 +43.6% Sep 30, 2016
Q2 2016 14.5 +2.71 +23% Jun 30, 2016
Q1 2016 13.2 +1.04 +8.53% Mar 31, 2016
Q4 2015 11.4 -1.32 -10.4% Dec 31, 2015
Q3 2015 11.2 +0.54 +5.08% Sep 30, 2015
Q2 2015 11.8 +1.08 +10.1% Jun 30, 2015
Q1 2015 12.2 +1.87 +18.1% Mar 31, 2015
Q4 2014 12.7 +0.88 +7.46% Dec 31, 2014
Q3 2014 10.6 -5.78 -35.2% Sep 30, 2014
Q2 2014 10.7 -8.47 -44.2% Jun 30, 2014
Q1 2014 10.3 -14 -57.5% Mar 31, 2014
Q4 2013 11.8 -17.8 -60.1% Dec 31, 2013
Q3 2013 16.4 -15.2 -48.1% Sep 30, 2013
Q2 2013 19.2 -13.1 -40.6% Jun 30, 2013
Q1 2013 24.3 Mar 31, 2013
Q4 2012 29.6 Dec 31, 2012
Q3 2012 31.6 Sep 30, 2012
Q2 2012 32.3 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.